Growth Dynamics on Parkinson's Disease Drugs Market 2020-2026

The Global Parkinson's Disease Drugs Market Share is likely to grow in the coming years due to the growing emphasis on the treatment of Parkinson's disease. According to a report published by Fortune Business Insights, titled “Parkinson’s Disease Drugs: Global Market Analysis, Insights and Forecast, 2019-2026,” the market was valued at US$ 4,500.0 Mn in 2018. Fortune Business Insights states that the market will reach US$ 8,383.2 Mn by 2026, thereby exhibiting a CAGR of 8.1%.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/parkinson-s-disease-drugs-market-100655

Detailed Table of Content:

· Introduction

o Research Scope

o Market Segmentation

o Research Methodology

o Definitions and Assumptions

· Executive Summary

· Market Dynamics

o Market Drivers

o Market Restraints

o Market Opportunities

o Market Trends

· Key Insights

o Prevalence of Parkinson's Disease - For Key Countries, 2018

o Regulatory Scenario - For Key Countries

o Patent Snapshot

· 4.4 New Product Launch

o Pipeline Analysis

o Key Industry Developments -Mergers, Acquisitions and Partnerships

· Global Parkinson's Disease Drugs Market Analysis, Insights and Forecast, 2014-2025

o Key Findings / Summary

o Market Analysis, Insights and Forecast – By Drug Class

§ Decarboxylase Inhibitors

§ DopamineAgonists

§ Monoamine Oxidase Type B (MAO-B) Inhibitors

§ Catechol-O-Methyltransferase (COMT) Inhibitors

§ Others

o Market Analysis, Insights and Forecast – By Route of Administration

§ Oral

§ Injection

§ Transdermal

o Market Analysis, Insights and Forecast – By Distribution Channel

§ Hospital Pharmacy

§ Retail Pharmacy

§ Online Stores

o Market Analysis, Insights and Forecast – By Region

§ North America

§ Europe

§ Asia Pacific

§ Latin America

§ Middle East & Africa